Variant report
Variant | nsv518221 |
---|---|
Chromosome Location | chr7:84905855-84911801 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs2178115 | chr7:84905855-84905856 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs534158086 | chr7:84905858-84905859 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs143108218 | chr7:84905864-84905865 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs34529642 | chr7:84905866-84905867 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs562234075 | chr7:84905939-84905940 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs370274778 | chr7:84905952-84905953 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs189282293 | chr7:84905975-84905976 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs10232768 | chr7:84905987-84905988 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs144964185 | chr7:84905994-84905995 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs528400193 | chr7:84906031-84906032 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs190606978 | chr7:84906043-84906044 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs7808114 | chr7:84906063-84906064 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs114890297 | chr7:84906073-84906074 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs533082348 | chr7:84906111-84906112 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs557179864 | chr7:84906131-84906132 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs569294204 | chr7:84906232-84906233 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs536266009 | chr7:84906243-84906244 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs554976366 | chr7:84906264-84906265 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs79046427 | chr7:84906295-84906296 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs2696163 | chr7:84906342-84906343 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs559290331 | chr7:84906365-84906366 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs555921930 | chr7:84906463-84906464 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs112360668 | chr7:84906469-84906470 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs192613195 | chr7:84906491-84906492 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs563250860 | chr7:84906504-84906505 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs7808888 | chr7:84906508-84906509 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs542339431 | chr7:84906594-84906595 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs560975854 | chr7:84906602-84906603 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs564947158 | chr7:84906606-84906607 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs185611214 | chr7:84906608-84906609 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs527297302 | chr7:84906614-84906615 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs142295263 | chr7:84906615-84906616 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs571163404 | chr7:84906651-84906652 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs12112660 | chr7:84906653-84906654 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs532186858 | chr7:84906658-84906659 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs12112018 | chr7:84906663-84906664 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs12112670 | chr7:84906669-84906670 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs201233408 | chr7:84906717-84906718 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs12113211 | chr7:84906718-84906719 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs28419163 | chr7:84906726-84906727 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs201888740 | chr7:84906738-84906739 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs35993399 | chr7:84906740-84906741 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs200086950 | chr7:84906754-84906755 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs200577477 | chr7:84906756-84906757 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs560953756 | chr7:84906757-84906758 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs375383157 | chr7:84906758-84906759 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs71523727 | chr7:84906759-84906760 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs34646619 | chr7:84906772-84906773 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs78432067 | chr7:84906773-84906774 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs12704122 | chr7:84906785-84906786 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 17170743 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Melanoma | 18172304 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Stenocardia | 21860640 | CNVD |
Vasospasm | 21860640 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 22495311 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Biliary cancer | 19435499 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Glioblastoma multiforme | 21750150 | CNVD |
Cancer | 21183584 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Gastric cancer | 24379144 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Lissencephaly | 21572526 | CNVD |
Breast cancer | 17603634 | CNVD |
Liposarcoma | 21253554 | CNVD |
Breast cancer | 16397240 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Low-grade fibromyxoid sarcoma | 0 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 21264507 | CNVD |
Shwachman-Diamond syndrome | 22934832 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Cutaneous malignant melanoma | 17690212 | CNVD |
Leukemia | 17361228 | CNVD |
Breast cancer | 16461572 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Malignant melanoma | 17690212 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Multiple myeloma | 17550852 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
abortions and stillbirths | 19751515 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 21364760 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Lung cancer | 18438408 | CNVD |
Williams-beuren syndrome | 16826523 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Wilms tumour | 19318497 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Schizophrenia | 17879154 | CNVD |
Prostate cancer | 16573809 | CNVD |
Prostate cancer | 16461572 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Autism | 20858243 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Breast cancer | 21611746 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:84902400-84906400 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
2 | chr7:84902600-84906400 | Enhancers | HUES64 Cell Line | embryonic stem cell |
3 | chr7:84902600-84906400 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
4 | chr7:84902800-84906400 | Enhancers | HUES6 Cell Line | embryonic stem cell |
5 | chr7:84904600-84906400 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
6 | chr7:84904600-84906400 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
7 | chr7:84905000-84906000 | Enhancers | ES-WA7 Cell Line | embryonic stem cell |
8 | chr7:84905000-84906200 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
9 | chr7:84905200-84906200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
10 | chr7:84905200-84906400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
11 | chr7:84905400-84906000 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
12 | chr7:84905400-84907000 | Enhancers | H1 Cell Line | embryonic stem cell |
13 | chr7:84905600-84906200 | Enhancers | H9 Cell Line | embryonic stem cell |
14 | chr7:84906200-84916000 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
15 | chr7:84909400-84910200 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
16 | chr7:84909800-84910200 | Enhancers | Fetal Heart | heart |
17 | chr7:84910200-84911200 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
18 | chr7:84911200-84912000 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |